OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,117,368 | -36.8% | 1,629,528 | +3.8% | 0.00% | 0.0% |
| Q2 2023 | $8,100,704 | +5.4% | 1,569,904 | +7.7% | 0.00% | 0.0% |
| Q1 2023 | $7,682,289 | +193750.3% | 1,457,740 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $3,963 | -99.9% | 1,410,653 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $5,688,000 | +4.7% | 1,370,753 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $5,432,000 | -19.5% | 1,351,425 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $6,751,000 | -26.5% | 1,363,970 | +3.5% | 0.00% | 0.0% |
| Q4 2021 | $9,181,000 | -30.0% | 1,317,339 | +0.4% | 0.00% | -50.0% |
| Q3 2021 | $13,122,000 | -29.1% | 1,312,235 | +0.6% | 0.00% | -33.3% |
| Q2 2021 | $18,502,000 | -8.3% | 1,304,799 | +6.1% | 0.00% | 0.0% |
| Q1 2021 | $20,177,000 | -10.6% | 1,229,608 | +12.8% | 0.00% | -25.0% |
| Q4 2020 | $22,570,000 | +234.8% | 1,090,351 | +23.1% | 0.00% | +300.0% |
| Q3 2020 | $6,741,000 | -0.5% | 885,906 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $6,774,000 | +108.4% | 813,258 | +23.8% | 0.00% | 0.0% |
| Q1 2020 | $3,250,000 | -28.0% | 656,651 | -42.5% | 0.00% | – |
| Q4 2019 | $4,514,000 | +180.7% | 1,142,838 | +116.1% | 0.00% | – |
| Q3 2019 | $1,608,000 | -19.7% | 528,948 | +16.2% | 0.00% | – |
| Q2 2019 | $2,003,000 | +24.1% | 455,285 | +12.0% | 0.00% | – |
| Q1 2019 | $1,614,000 | -42.2% | 406,560 | -42.0% | 0.00% | – |
| Q4 2018 | $2,790,000 | +33.2% | 701,346 | +130.4% | 0.00% | -100.0% |
| Q3 2018 | $2,094,000 | +7.3% | 304,392 | +5.3% | 0.00% | 0.0% |
| Q2 2018 | $1,952,000 | +27.9% | 289,194 | +23.3% | 0.00% | – |
| Q1 2018 | $1,526,000 | +94.9% | 234,545 | +33.3% | 0.00% | – |
| Q4 2017 | $783,000 | -32.6% | 176,010 | -6.3% | 0.00% | – |
| Q3 2017 | $1,161,000 | -31.1% | 187,898 | +3.3% | 0.00% | -100.0% |
| Q2 2017 | $1,686,000 | +3.6% | 181,885 | +3.7% | 0.00% | 0.0% |
| Q1 2017 | $1,627,000 | +40.1% | 175,361 | +26.4% | 0.00% | 0.0% |
| Q4 2016 | $1,161,000 | +24.3% | 138,732 | +2.0% | 0.00% | – |
| Q3 2016 | $934,000 | +147.7% | 136,069 | +78.5% | 0.00% | – |
| Q2 2016 | $377,000 | -44.6% | 76,212 | +8.3% | 0.00% | – |
| Q1 2016 | $680,000 | +4.8% | 70,396 | +1.5% | 0.00% | – |
| Q4 2015 | $649,000 | -32.4% | 69,354 | +1.5% | 0.00% | -100.0% |
| Q3 2015 | $960,000 | -28.7% | 68,320 | +6.7% | 0.00% | 0.0% |
| Q2 2015 | $1,346,000 | -8.9% | 64,051 | +81.9% | 0.00% | 0.0% |
| Q1 2015 | $1,478,000 | +120.9% | 35,207 | +23.7% | 0.00% | – |
| Q4 2014 | $669,000 | +192.1% | 28,464 | +86.0% | 0.00% | – |
| Q3 2014 | $229,000 | – | 15,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |